Inonu University
inonu.edu.trTotal trials
335
Active
68
Phase 3
0
Total enrollment
31,620
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 2 of 2 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| 0.12% Chlorhexidine Gluconate Mouthwash | — | — | — | — | — | 1 | |
| 5% Morus Nigra Mouthwash | — | — | — | — | — | 1 |
Next readouts
- 2026-06-01
Top conditions
- Anesthesia9
- Pregnancy Related9
- Acute Kidney Injury7
- Pain7
- Anxiety7
- Morbid Obesity6
- Quality of Life6
- Nursing Students6
Frequently asked questions about Inonu University
- How many clinical trials does Inonu University have on ClinicalTrials.gov?
- Inonu University is listed as the lead sponsor on 335 clinical trials in ClinicalTrials.gov, 68 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Inonu University's trials are in Phase 3?
- 0 of Inonu University's trials are in Phase 3, spread across 2 active drug programs.
- What therapeutic areas does Inonu University focus on?
- Inonu University's most-studied conditions on ClinicalTrials.gov are Anesthesia, Pregnancy Related, Acute Kidney Injury, Pain, Anxiety.
- When are Inonu University's next clinical trial readouts?
- Inonu University has 1 upcoming primary-completion readout tracked here; the soonest is “Efficacy of Chlorhexidine and Morus Nigra Mouthwashes After Periodontal Treatment”, expected around 2026-06-01.